School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou 510006, China.
Bioorg Med Chem Lett. 2012 May 1;22(9):3261-4. doi: 10.1016/j.bmcl.2012.03.026. Epub 2012 Mar 21.
Phosphodiesterase-4 (PDE4) has been identified to be a promising target for treatment of asthma. Moracin M extracted from Chinese herbal drug 'Sang-Bai-Pi' (Morus alba L.) was studied for the inhibitory affinity towards PDE4. It inhibited PDE4D2, PDE4B2, PDE5A1, and PDE9A2 with the IC(50) values of 2.9, 4.5, >40, and >100 μM, respectively. Our molecular docking and 8ns molecular dynamics (MD) simulations demonstrated that moracin M forms three hydrogen bonds with Gln369, Asn321, and Asp318 in the active site and stacks against Phe372. In addition, comparative kinetics analysis of its analog moracin C was carried out to qualitatively validate their inhibitory potency as predicted by the binding free energy calculations after MD simulations.
磷酸二酯酶-4(PDE4)已被确定为治疗哮喘的有前途的靶点。从中药“桑白皮”(桑白皮)中提取的桑辛 M 被研究其对 PDE4 的抑制亲和力。它分别抑制 PDE4D2、PDE4B2、PDE5A1 和 PDE9A2 的 IC50 值为 2.9、4.5、>40 和>100 μM。我们的分子对接和 8ns 分子动力学(MD)模拟表明,桑辛 M 与活性位点中的 Gln369、Asn321 和 Asp318 形成三个氢键,并与 Phe372 堆叠。此外,对其类似物桑辛 C 的比较动力学分析进行了,以定性验证它们的抑制效力,这是通过 MD 模拟后的结合自由能计算预测的。